Published in Clin Infect Dis on September 01, 1998
Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev (2003) 3.39
PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J Clin Microbiol (2000) 1.68
Seasonal dynamics of Anaplasma phagocytophila in a rodent-tick (Ixodes trianguliceps) system, United Kingdom. Emerg Infect Dis (2003) 1.50
Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J Clin Microbiol (1999) 1.47
High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany. J Clin Microbiol (2003) 1.41
Prevalence of Borrelia burgdorferi and granulocytic and monocytic ehrlichiae in Ixodes ricinus ticks from southern Germany. J Clin Microbiol (1999) 1.33
Ixodes ricinus and Its Transmitted Pathogens in Urban and Peri-Urban Areas in Europe: New Hazards and Relevance for Public Health. Front Public Health (2014) 1.30
Dusky-footed wood rats (Neotoma fuscipes) as reservoirs of granulocytic Ehrlichiae (Rickettsiales: Ehrlichieae) in northern California. J Clin Microbiol (1999) 1.25
Expression of interleukin-1beta, tumor necrosis factor alpha, and interleukin-6 in human peripheral blood leukocytes exposed to human granulocytic ehrlichiosis agent or recombinant major surface protein P44. Infect Immun (2000) 1.23
Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Immunol (2001) 1.07
PCR detection and serological evidence of granulocytic ehrlichial infection in roe deer (Capreolus capreolus) and chamois (Rupicapra rupicapra). J Clin Microbiol (2002) 1.07
Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. J Clin Microbiol (1999) 1.04
A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic anaplasma phagocytophilum (HGE agent) in Germany. Eur J Clin Microbiol Infect Dis (2003) 1.03
PCR amplification and phylogenetic analysis of groESL operon sequences from Ehrlichia ewingii and Ehrlichia muris. J Clin Microbiol (2000) 1.02
Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob Agents Chemother (2001) 0.99
High prevalence of granulocytic Ehrlichiae and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Bulgaria. J Clin Microbiol (2001) 0.96
Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother (2003) 0.90
Multilocus sequence analysis of Anaplasma phagocytophilum reveals three distinct lineages with different host ranges in clinically ill French cattle. Vet Res (2014) 0.85
Detection of Anaplasma phagocytophilum DNA in Ixodes ticks (Acari: Ixodidae) from Madeira Island and Setubal District, mainland Portugal. Emerg Infect Dis (2004) 0.85
First European pediatric case of human granulocytic ehrlichiosis. J Clin Microbiol (2001) 0.82
Serologic evidence of Anaplasma phagocytophilum infections in patients with a history of tick bite in central Slovakia. Wien Klin Wochenschr (2008) 0.81
First described case of human granulocytic anaplasmosis in a patient in Eastern Austria. Wien Med Wochenschr (2010) 0.80
Transmission of Anaplasma phagocytophilum to Ixodes ricinus ticks from sheep in the acute and post-acute phases of infection. Infect Immun (2003) 0.80
First documented case of human granulocytic ehrlichiosis in Austria. Wien Klin Wochenschr (2003) 0.76
Molecular diagnosis and genetic diversity of tick-borne Anaplasmataceae agents infecting the African buffalo Syncerus caffer from Marromeu Reserve in Mozambique. Parasit Vectors (2016) 0.75
All ras proteins are polyisoprenylated but only some are palmitoylated. Cell (1989) 9.68
Isolation of Legionella spp. from environmental water samples by low-pH treatment and use of a selective medium. J Clin Microbiol (1981) 6.88
Catabolite repression of alpha-amylase gene expression in Bacillus subtilis involves a trans-acting gene product homologous to the Escherichia coli lacl and galR repressors. Mol Microbiol (1991) 4.04
Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol (1992) 3.81
Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46
Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med (1999) 3.45
Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol (1997) 3.28
Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol (1998) 3.15
A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95
Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg (1993) 2.84
Distribution, diversity, and host specificity of Bartonella in rodents from the Southeastern United States. Am J Trop Med Hyg (1997) 2.77
The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful. Clin Microbiol Infect (2014) 2.62
PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol (1997) 2.59
The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg Infect Dis (1996) 2.45
Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosis. J Clin Microbiol (1994) 2.44
Association of intraspecific wounding with hantaviral infection in wild rats (Rattus norvegicus). Epidemiol Infect (1988) 2.37
Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36
Ecologic studies of rodent reservoirs: their relevance for human health. Emerg Infect Dis (1999) 2.32
An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 2.32
Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (2011) 2.23
The human ehrlichioses in the United States. Emerg Infect Dis (1999) 2.22
Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med (1995) 2.15
Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis (1999) 2.05
Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J Infect Dis (1999) 2.03
Isolation and characterization of a cis-acting mutation conferring catabolite repression resistance to alpha-amylase synthesis in Bacillus subtilis. J Bacteriol (1985) 1.99
Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med (1998) 1.95
Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol (1997) 1.91
A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am J Trop Med Hyg (1992) 1.86
Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. Emergency ID Net Study Group. JAMA (2000) 1.83
Antigenic characteristics of isolates associated with a new epizootic of raccoon rabies in the United States. J Infect Dis (1984) 1.72
National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg (1995) 1.72
Ehrlichiosis in a golf-oriented retirement community. N Engl J Med (1995) 1.71
Prevalence of antibody to hepatitis E virus among rodents in the United States. J Infect Dis (2000) 1.70
Search for the Ebola virus reservoir in Kikwit, Democratic Republic of the Congo: reflections on a vertebrate collection. J Infect Dis (1999) 1.70
Transmission of the agent of human granulocytic ehrlichiosis by Ixodes spinipalpis ticks: evidence of an enzootic cycle of dual infection with Borrelia burgdorferi in Northern Colorado. J Infect Dis (2000) 1.70
PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J Clin Microbiol (2000) 1.68
Rabies surveillance in the United States during 1993. J Am Vet Med Assoc (1994) 1.67
Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand. Epidemiol Infect (2010) 1.65
Immunoblot analysis of immunoglobulin G response to the Lyme disease agent (Borrelia burgdorferi) in experimentally and naturally exposed dogs. J Clin Microbiol (1988) 1.59
Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol (1999) 1.58
Role of the spore coat layers in Bacillus subtilis spore resistance to hydrogen peroxide, artificial UV-C, UV-B, and solar UV radiation. Appl Environ Microbiol (2000) 1.56
White-tailed deer as a potential reservoir of Ehrlichia spp. J Wildl Dis (1994) 1.53
Molecular cloning and characterization of the Ehrlichia chaffeensis variable-length PCR target: an antigen-expressing gene that exhibits interstrain variation. J Clin Microbiol (1999) 1.51
Hantavirus (Bunyaviridae) infections in rodents from Orange and San Diego counties, California. Am J Trop Med Hyg (1999) 1.51
Assessing the role of long-distance translocation and spatial heterogeneity in the raccoon rabies epidemic in Connecticut. Prev Vet Med (2005) 1.50
Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis (2001) 1.49
Small mammal survival and trapability in mark-recapture monitoring programs for hantavirus. J Wildl Dis (1998) 1.49
Experimental evaluation of rodent exclusion methods to reduce hantavirus transmission to humans in rural housing. Am J Trop Med Hyg (1997) 1.47
A survey of hantavirus antibody in small-mammal populations in selected United States National Parks. Am J Trop Med Hyg (1998) 1.47
Evaluation of intraspecies genetic variation within the 60 kDa heat-shock protein gene (groEL) of Bartonella species. Int J Syst Bacteriol (1999) 1.47
Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J Clin Microbiol (1999) 1.47
Bartonella sp. bacteremia in patients with neurological and neurocognitive dysfunction. J Clin Microbiol (2008) 1.46
Diversity of Babesia Infecting European sheep ticks (Ixodes ricinus). J Clin Microbiol (2001) 1.45
Intradermal use of human diploid cell vaccine for preexposure rabies immunizations. J Am Vet Med Assoc (1982) 1.45
Isolation of Borrelia burgdorferi sensu lato from blood of adult patients with borrelial lymphocytoma, Lyme neuroborreliosis, Lyme arthritis and acrodermatitis chronica atrophicans. Infection (2010) 1.44
Sequence analysis of the ank gene of granulocytic ehrlichiae. J Clin Microbiol (2000) 1.42
Hemorrhagic fever with renal syndrome in the Dolenjska region of Slovenia--a 10-year survey. Clin Infect Dis (1999) 1.42
The subunit structure and catalytic mechanism of the Bacillus subtilis DNA repair enzyme spore photoproduct lyase. Proc Natl Acad Sci U S A (2001) 1.41
Leukopenia, thrombocytopenia, and Lyme borreliosis: is there an association? Clin Infect Dis (1997) 1.40
Genetic analysis of wild-type Dobrava hantavirus in Slovenia: co-existence of two distinct genetic lineages within the same natural focus. J Gen Virol (2000) 1.40
Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment. Minerva Med (2009) 1.38
An outbreak of acute bartonellosis (Oroya fever) in the Urubamba region of Peru, 1998. Am J Trop Med Hyg (1999) 1.37
Epizootiology of Hantavirus infections in Baltimore: isolation of a virus from Norway rats, and characteristics of infected rat populations. Am J Epidemiol (1987) 1.33
Serologic evidence of infection with Ehrlichia spp. in wild rodents (Muridae: Sigmodontinae) in the United States. J Clin Microbiol (1998) 1.32
Spore photoproduct lyase from Bacillus subtilis spores is a novel iron-sulfur DNA repair enzyme which shares features with proteins such as class III anaerobic ribonucleotide reductases and pyruvate-formate lyases. J Bacteriol (1998) 1.32
Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J Public Health Manag Pract (1998) 1.32
Spatiotemporal analysis of epizootic raccoon rabies propagation in Connecticut, 1991-1995. Vector Borne Zoonotic Dis (2002) 1.30
Molecular cloning and characterization of the Bacillus subtilis spore photoproduct lyase (spl) gene, which is involved in repair of UV radiation-induced DNA damage during spore germination. J Bacteriol (1993) 1.30
Patient isolates of Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities of strain 25015. J Infect Dis (1996) 1.29
Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion (2000) 1.29
Rabies surveillance in the United States during 1994. J Am Vet Med Assoc (1995) 1.29
Current issues in rabies prevention in the United States health dilemmas. Public coffers, private interests. Public Health Rep (1996) 1.29
Long-term studies of hantavirus reservoir populations in the southwestern United States: rationale, potential, and methods. Emerg Infect Dis (1999) 1.28
Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. Am J Public Health (1996) 1.28
Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island. J Clin Microbiol (1997) 1.26
Global survey of antibody to Hantaan-related viruses among peridomestic rodents. Bull World Health Organ (1986) 1.25
Dusky-footed wood rats (Neotoma fuscipes) as reservoirs of granulocytic Ehrlichiae (Rickettsiales: Ehrlichieae) in northern California. J Clin Microbiol (1999) 1.25
Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy. J Infect Dis (2001) 1.25
Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med (1996) 1.24
Evidence of rodent-associated Bartonella and Rickettsia infections among intravenous drug users from Central and East Harlem, New York City. Am J Trop Med Hyg (2001) 1.24
Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron (1994) 1.23
Infection with a ratborne hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis (1993) 1.22
Anti-tick saliva antibody: a biologic marker of tick exposure that is a risk factor for Lyme disease seropositivity. Am J Epidemiol (1991) 1.22
Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J Infect Dis (2000) 1.22
Evaluation of a canine rabies vaccination campaign and characterization of owned-dog populations in the Philippines. Southeast Asian J Trop Med Public Health (1996) 1.22
Sigma-G RNA polymerase controls forespore-specific expression of the glucose dehydrogenase operon in Bacillus subtilis. Nucleic Acids Res (1989) 1.22
Urban zoonoses caused by Bartonella, Coxiella, Ehrlichia, and Rickettsia species. Vector Borne Zoonotic Dis (2001) 1.19
The two major spore DNA repair pathways, nucleotide excision repair and spore photoproduct lyase, are sufficient for the resistance of Bacillus subtilis spores to artificial UV-C and UV-B but not to solar radiation. Appl Environ Microbiol (1996) 1.17
Comparison of the epidemiological and clinical features of tick-borne encephalitis in children and adults. Infection (2000) 1.17